Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;
2025 · 2nd Quarter (Apr 1 - June 30)
ERVIN GRAVES STRATEGY LLC ON BEHALF OF BYHEART INC
Filed by BURRELL INTERNATIONAL GROUP LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- $20,000.00
- Expenses
- Not reported
- Registrant
- BURRELL INTERNATIONAL GROUP LLC
- Filing UUID
- 36da7349-91e8-4110-84c6-f00e9caadad3
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations; FY26 AG Appropriations for infant formula manufacturing, and tax credit for domestic infant formula manufacturing; FDA and Domestic Infant Formula Manufacturing and Tax Credits;
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.